Thermo Fisher Scientific (TMO) Confirms Offer to Acquire QIAGEN (QGEN) Shares Expires on August 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
UPDATE: Qiagen (QGEN) Tops Q2 EPS by 9c, Revenues Beat; Boards Reaffirms Unanimous Recommendation Shareholders Accept Thermo Fisher (TMO) Offer
August 4, 2020 4:21 PM EDT(Updated - August 4, 2020 4:22 PM EDT)
Qiagen (NYSE: QGEN) reported Q2 EPS of $0.55, $0.09 better than the analyst estimate of $0.46. Revenue for the quarter came in at $443.3 million versus the consensus estimate of $425.82 million.
Q2 2020 results:Net sales of $443.3 million (+16% actual, +19% CER)Diluted EPS $0.38; adjusted EPS $0.55 ($0.56 CER, +70% CER)H1 2020 results:Net sales of $815.3 million (+12% actual, +14% CER)Diluted EPS $0.56; adjusted EPS $0.89 ($0.90 CER, +50% CER)QIAGEN Boards have reaffirmed unanimous recommendation that QIAGEN... More